Presentations

Keynote lecture
Claire ANDREJAK, CHU Amiens-Picardie, Présidente SPLF (Société de Pneumologie de Langue Française)
Maladies respiratoires = un réel enjeu de santé publique en 2024

Session 1 – Research and Innovations

Olivier MONCORGÉ, IRIM – UMR9004 (Institut de Recherche en Infectiologie de Montpellier)
Prepared for the next virus pandemic: The APPEAL project

Mustapha SI-TAHAR, INSERM, Université de Tours
Metabolic control of lung inflammation

Geneviève HÉRY-ARNAUD, INSERM U1078, CHU Brest, Faculté de Médecine, Université de Brest
Lung microbiota: a new frontier in diagnosing and treating respiratory diseases

Session 2 – Experimental models

Christian PELLEVOISIN, MatTek
Applications of 3D tissue engineering of the human upper and lower respiratory system in basic and applied research

Hanan OSMAN-PONCHET, PKDERM
Advances in In Vitro Modeling of Lung Diseases: Focus on Precision-Cut Lung Slices (PCLS) Model

Andrea BENASSI, Chiesi
Developing a digital twin of the human respiratory system

Erwan CORCUFF, Cynbiose
A preclinical platform for the investigation of respiratory viral infections in the NHP model

Session 3 – Innovative therapeutics and diagnostics approaches

Sylvia COHEN-KAMINSKY, Directrice de recherche CNRS, Inserm UMR_S999, Université Paris Saclay
The vascular NMDA receptor in PAH (Pulmonary Arterial Hypertension), an out-of-the-box academic scientific strategy towards therapeutic innovation

Thomas GUILLARD, Université de Reims Champagne-Ardenne, Inserm UMR S 1250 P3Cell, CHU de Reims, Laboratoire de bactériologie-Virologie-Hygiène hospitalière, Reims, France
Lessons Learned from Using the FilmArray Pneumonia Panel Plus in the Field

Nelly BADALATO, GenoScreen
Advancing tuberculosis drug resistance diagnosis with targeted next generation sequencing

Flash Scientific Posters

Patrice MOREL, SATT OUEST VALORISATION
New treatment to prevent asthma

Alice TRAUSCH, VOXCAN
Miniaturized primary airway epithelia and reporter viruses development for antiviral drug screening against respiratory viruses

Fabienne ARCHER, IVPC – INRAE-Univ Lyon1
Generating complex physiological lung tissue using 3d bioprinting to study respiratory pathologies

Safaa MAWAS, Université Paris Cité – CNRS UMR 8251
Inhaled nanoplastics as vectors for Benzo(a)pyrene: Unveiling a synergistic mechanism of airway toxicity

Flash Corporate Presentations

Abdel-Kader DIAW, Chiesi

Samuel CONSTANT, Epithelix

Miroslav KANĎÁR, MatTek

Session 4 – Prevention, inner air pollution and environmental aspects

Samuel CONSTANT, Epithelix
Advanced immunocompetent in vitro primary human lung models for toxicity evaluation of airborne fibers and nanomaterials

Didier LECOINTE, CHSF
Prevention of viral respiratory infections

Franz DURANDET, IAGE (Ingéniérie et Analyse Génétique Environnementale) Montpellier
Early detection and quantification of human pathogens in the environment

Fabien SQUINAZI, Faculté de médecine de Paris
Sanitary warnings to the population and medical care professionals in case of atmospheric pollution episodes

Evelyne GÉHIN, Université Paris-Est Créteil
Strategy of ventilation and aeration of facilities in case of exceptional epidemic situation

Philippe DUQUENNE, INRS
Prevention of occupational biological risks in a context of poly-exposure « biological agents/chemical substances »: a few examples